These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35340124)

  • 1. The clinical utility and thresholds of virtual and Halifaster flow crossmatches in lung transplantation.
    Hiho SJ; Levvey B; Carroll R; Nicolson I; Mihaljcic M; Diviney MB; Snell GI; Sullivan LC; Westall GP
    HLA; 2022 Jun; 99(6):580-589. PubMed ID: 35340124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
    Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
    Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes.
    Gandhi MJ; DeGoey SR; Bundy K; Kremers WK; Knauer R; Pereira N; Edwards B; Kushwaha S; Daly RC
    Transplant Proc; 2011 Dec; 43(10):3840-6. PubMed ID: 22172857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
    Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
    Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.
    Locke AF; Hickey M; Valenzuela NM; Butler C; Sosa R; Zheng Y; Gjertson D; Reed EF; Zhang Q
    Transplantation; 2023 Aug; 107(8):1776-1785. PubMed ID: 36944607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive virtual crossmatch with negative flow crossmatch results in two cases.
    Jacob EK; De Goey SR; Gandhi MJ
    Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSA-FXM: Accelerated Donor-specific Flow Crossmatch Discriminating Class I and II Antibody Specifically and Only to Donor HLA for Determining True Incompatibility.
    Chen G; Lin L; Tyan DB
    Transplantation; 2020 Apr; 104(4):813-822. PubMed ID: 31385929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
    Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
    Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.
    Eby BC; Redfield RR; Ellis TM; Leverson GE; Schenian AR; Odorico JS
    Transplantation; 2016 May; 100(5):1103-10. PubMed ID: 26950720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
    Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.
    Visentin J; Bachelet T; Borg C; Franchini N; Nong T; Lee JH; Couzi L; Merville P; Guidicelli G; Taupin JL
    Transplantation; 2017 Mar; 101(3):624-630. PubMed ID: 27336398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing transplantation of sensitized heart candidates using 4 antibody detection assays to prioritize the assignment of unacceptable antigens.
    Reinsmoen NL; Patel J; Mirocha J; Lai CH; Naim M; Ong G; Wang Q; Zhang X; Liou F; Yu Z; Kobashigawa J
    J Heart Lung Transplant; 2016 Feb; 35(2):165-72. PubMed ID: 26683810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-MFI (median fluorescence intensity) pre-transplant DSA (donor specific antibodies) leading to anamnestic antibody mediated rejection in live-related donor kidney transplantation.
    Chauhan R; Tiwari AK; Aggarwal G; Gowri Suresh L; Kumar M; Bansal SB
    Transpl Immunol; 2023 Dec; 81():101931. PubMed ID: 37730185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation.
    Riethmüller S; Ferrari-Lacraz S; Müller MK; Raptis DA; Hadaya K; Rüsi B; Laube G; Schneiter G; Fehr T; Villard J
    Transplantation; 2010 Jul; 90(2):160-7. PubMed ID: 20658760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of Luminex-based donor-specific antibody mean fluorescence intensity values with complement-dependent cytotoxicity & flow crossmatch results in live donor renal transplantation.
    Baranwal AK; Bhat DK; Goswami S; Agarwal SK; Kaur G; Kaur J; Mehra N
    Indian J Med Res; 2017 Feb; 145(2):222-228. PubMed ID: 28639599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.